Last10K.com

Item 9 Labs Corp. (INLB) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2019

Item 9 Labs Corp.

CIK: 1500123 Ticker: INLB
Document and Entity Information - USD ($)
12 Months Ended
Sep. 30, 2019
Jan. 13, 2020
Jun. 30, 2019
Cover [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Period End DateSep. 30, 2019  
Current Fiscal Year End Date--09-30  
Entity File Number000-54730  
Entity Registrant NameItem 9 Labs Corp.  
Entity Central Index Key0001500123  
Entity Incorporation, State or Country CodeDE  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 43,679,786
Entity Common Stock, Shares Outstanding 63,652,620 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2019  

View differences made from one year to another to evaluate Item 9 Labs Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Item 9 Labs Corp..

Continue

Assess how Item 9 Labs Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Item 9 Labs Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Operations
Acquisition - Summary Of Azdpc Revenue, Expense And Net Income (Details)
Business Combination
Business Combination (Details Narrative)
Business Combination (Tables)
Business Combination??- Future Amortization Of Identifiable Intangible Assets (Details)
Business Combination??- Identifiable Intangible Assets (Details)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Concentrations
Concentrations (Details Narrative)
Going Concern
Income Taxes
Income Taxes (Tables)
Income Taxes - Effective Income Tax Rate Reconciliation (Details)
Income Taxes - Income Tax Provision Computed On Taxable Income Since Reverse Merger (Details)
Long Term Debt In Default
Long Term Debt In Default (Details Narrative)
Notes Receivable
Notes Receivable (Details Narrative)
Property And Equipment, Net
Property And Equipment, Net (Details Narrative)
Property And Equipment, Net (Tables)
Property And Equipment, Net - Summary Of Property And Equipment (Details)
Related Party Transactions
Related Party Transactions (Details Narrative)
Sale Of Airware Assets And Investment In Health Defense Llc
Sale Of Airware Assets And Investment In Health Defense Llc (Details Narrative)
Short Term Note Payable
Short Term Note Payable (Details Narrative)
Stockholders' Equity
Stockholders' Equity (Details Narrative)
Stockholders' Equity (Tables)
Stockholders' Equity - Assumptions Used For Determining Fair Value Of Options Granted (Details)
Stockholders' Equity - Summary Of Stock Option Activity (Details)
Stockholders' Equity - Warrants Outstanding (Details)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Activity Of Discontinued Operations (Details)
Unsecured Convertible Note Payable
Unsecured Convertible Note Payable (Details Narrative)
Variable Interest Entity
Variable Interest Entity (Details Narrative)

Material Contracts, Statements, Certifications & more

Item 9 Labs Corp. provided additional information to their SEC Filing as exhibits

Ticker: INLB
CIK: 1500123
Form Type: 10-K Annual Report
Accession Number: 0001554795-20-000013
Submitted to the SEC: Tue Jan 14 2020 5:17:48 PM EST
Accepted by the SEC: Tue Jan 14 2020
Period: Monday, September 30, 2019
Industry: Dental Equipment And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/inlb/0001554795-20-000013.htm